Description
Baricitinib, marketed under the brand name Olumiant among others, is a medication used for the treatment of rheumatoid arthritis and atopic dermatitis. It belongs to a class of medications known as Janus kinase inhibitors (JAK inhibitors), which work by blocking certain enzymes in the body that are involved in the inflammation process.
In the case of atopic dermatitis, baricitinib is prescribed for adults who have moderate to severe forms of the condition and have not responded well to topical treatments or other systemic therapies.
As with any medication, baricitinib can cause side effects, including an increased risk of infections, changes in blood cell counts, liver enzyme elevations, and an increased risk of blood clots. Therefore, it’s crucial to use this medication under the supervision of a healthcare professional who can monitor for any adverse effects and adjust the treatment plan as needed.
It’s important to follow your healthcare provider’s instructions carefully when taking baricitinib and to report any side effects or concerns promptly. Additionally, regular monitoring of your condition and laboratory tests may be necessary while taking this medication.
